What is ayahuasca? Ayahuasca is a psychedelic brew originating from the Amazon, originally used by indigenous populations and later involved for local syncretic purposes. Since it’s origins, ayahuasca has spread across the world and has developed a more varied list of uses. The two hallmark ingredients of ayahuasca are: 1) the leaves of the Psychotria …
In this Drug Science webinar, Dr Balázs Szigeti explains the current science of microdosing as he presents the results from his self-blinded microdosing research, the largest placebo-controlled microdosing study in the world! Dr Szigeti also explains how participants created their microdoses with a placebo control as part of the revolutionary methodology he developed to reduce …
After the release of the first comparison of psilocybin with an SSRI antidepressant, Michelle Baker Jones & Leonie Schneider explain what psilocybin therapy for depression involves. Leonie was a patient of Michelle in psilodep 1, and together they provide insight into psilocybin therapy from the perspective of both therapist and patient. Michelle Baker Jones is …
Psilocybin for depression is one of the most promising applications of psychedelic therapy. In particular, psilocybin therapy is being studied as an alternative to antidepressants in the treatment of treatment-resistant depression. In this Drug Science webinar, Dr Mourad Wahba explains the science behind psilocybin for depression, which is currently in clinical trials at a number …
Dr Ben Sessa – MDMA for Alcohol Use Disorder Dr Ben Sessa presents the first data from the open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder. At this stage, seven participants have completed the full 8-week MDMA-assisted psychotherapy treatment course, …
Dr Meg Spriggs – Psilocybin for Anorexia Nervosa Dr Meg Spriggs is a researcher at the Centre for Psychedelic Research at Imperial College London where she works as a trial-coordinator and guide on trials of psilocybin. Her primary role is as one of the lead researchers on the Centre’s upcoming clinical trial assessing psilocybin-assisted psychotherapy …